Racial and ethnic minorities that are underrepresented in medicine have even lower representation in leadership of NCI-designated cancer centers, a study by Memorial Sloan Kettering Cancer Center researchers found.
Miruna Sasu spent more than 20 years as a digital health and innovation expert at life sciences companies—then came a realization
Cheryl Willman was named executive director of Mayo Clinic Cancer Programs and director of Mayo Clinic Comprehensive Cancer Center. Her transition to Mayo will occur sometime in August, officials said.
As American life returns to a semblance of normalcy, it may be time for President Biden’s administration to prioritize building a national digital health infrastructure.
Small dreams have no power to move hearts, and in a new six-year strategic plan, St. Jude Children’s Research Hospital is thinking very big. What would it take to drastically increase cure rates for childhood cancer worldwide?
Gynecologic oncologist Sarah Temkin has observed and experienced sexism in many venues: in hospital inpatient units, in the clinic infusion site, in the emergency room, but nothing is more blatant than sexism in the operating room.
Christian Hinrichs recently moved to a new role, as chief of the Section of Cancer Immunotherapy and co-director of the Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute of New Jersey.
In a three-day meeting this week, the FDA Oncologic Drugs Advisory Committee will be asked to determine viability of six indications for drugs that target PD-/PD-L1 proteins.
The boundary between basic science and engineering has been the subject of animated discussions in cancer research for quite some time. Where does science end and engineering begin? Is that boundary porous? How does it shift over time?
Karen E. Knudsen was named CEO of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network.
